ImageneBio, Inc. (IMA) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $392.96M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-51.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $364.00M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-17.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $363.09M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $87.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $362.87M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $94.00K.
ImageneBio, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | (m) | $392.96M | $-51.00K | $-250.85M | $142.07M | 3 month · $911.00K | (m) |
| 2026-03-31 | $0.00 | (m) | $364.00M | $-17.00K | $-240.67M | $123.33M | 3 month · $876.00K | (m) |
| 2025-12-31 | $0.00 | (m) | $363.09M | $87.00K | $-230.05M | $133.14M | 12 month · $15.39M | 12 month · $-7.05M |
| 2025-09-30 | (m) | (m) | $362.87M | $94.00K | $-223.14M | $139.83M | 3 month · $15.28M | 3 month · $-846.00K |
| 2025-06-30 | (m) | $48.00K | $458.80M | $65.00K | $-343.00M | $-180.35M | 3 month · $458.00K | 3 month · $-3.15M |
| 2025-03-31 | (m) | $48.00K | $458.34M | $99.00K | $-340.24M | $-169.60M | 3 month · $57.00K | 3 month · $-3.05M |
| 2024-12-31 | (m) | $48.00K | $2.16M | $-1.79M | $-179.90M | $-160.56M | 12 month · $5.29M | 12 month · $-11.82M |
| 2024-09-30 | (m) | $48.00K | $456.44M | $240.00K | $-322.50M | $-152.75M | 3 month · $1.02M | 3 month · $-3.00M |
| 2024-06-30 | (m) | $48.00K | $455.42M | $-350.00K | $-312.26M | $-146.57M | 3 month · $1.28M | 3 month · $-2.91M |
| 2024-03-31 | (m) | $48.00K | $454.14M | $-313.00K | $-298.53M | $-137.35M | 3 month · $2.00M | 3 month · $-2.85M |
| 2023-12-31 | (m) | $48.00K | $452.14M | $-48.00K | $-282.38M | $-126.11M | 12 month · $7.63M | (m) |
| 2023-09-30 | (m) | $44.00K | $418.49M | $-290.00K | $-262.90M | $155.34M | 3 month · $2.00M | (m) |
| 2023-06-30 | (m) | $42.00K | $402.67M | $-456.00K | $-245.55M | $156.70M | 3 month · $1.88M | (m) |
| 2023-03-31 | (m) | $36.00K | $363.92M | $-491.00K | $-228.44M | $135.02M | 3 month · $2.00M | (m) |
| 2022-12-31 | (m) | $36.00K | $361.92M | $-763.00K | $-214.22M | $146.97M | 12 month · $7.53M | (m) |
| 2022-09-30 | (m) | $36.00K | $360.06M | $-1.18M | $-200.12M | $158.79M | 3 month · $1.81M | (m) |
| 2022-06-30 | (m) | $36.00K | $358.22M | $-1.10M | $-182.78M | $174.37M | 3 month · $1.96M | (m) |
| 2022-03-31 | (m) | $36.00K | $355.69M | $-478.00K | $-162.29M | $192.96M | 3 month · $1.90M | (m) |
| 2021-12-31 | (m) | $36.00K | $353.30M | (m) | $-145.45M | $207.88M | 12 month · $5.18M | (m) |
| 2021-09-30 | (m) | $36.00K | $351.48M | (m) | $-148.25M | $203.26M | 3 month · $1.45M | (m) |
| 2021-06-30 | (m) | $36.00K | $349.96M | (m) | $-133.74M | $216.26M | 3 month · $1.26M | (m) |
| 2021-03-31 | (m) | $36.00K | $348.66M | (m) | $-121.06M | $227.64M | 3 month · $885.00K | (m) |
| 2020-12-31 | (m) | $3.00K | $10.29M | (m) | $-111.34M | $-101.05M | 12 month · $1.80M | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $-78.50M | 3 month · $418.00K | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-72.70M | 3 month · $354.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-68.01M | 3 month · $375.00K | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $-61.46M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |